A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study To Evaluate The Incidence Of Gastric Ulcers With PN 400 Versus Diclofenac/Misoprostol In Subjects Who Are At High Risk Of Developing
NSAID-Associated Ulcers
Summary: This is an approximately 6 month clinical research study of an investigational (not approved by the FDA) medication to determine its safety and effectiveness in controlling pain with less stomach irritation in patients at high risk for developing stomach ulcers.
Participation qualifications:
- Age 18 years or older
- Require use of pain relievers daily for treatment of chronic pain due to osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, or other chronic medical condition
- Have a history of an ulcer-related upper gastrointestinal condition, such as bleeding, perforation, or obstruction
- Must be willing to attend at least 6 clinic visits over a 6 month period
Benefits:
Study participants may receive study-related physical examinations, laboratory testing, and study medication.
Reimbursement for time and travel is also available.
If
you are interested in this study, please contact:
ACRC/Arizona Clinical
Research Center, Inc.
1825 N. Kolb Rd.
Tucson, AZ 85715
Phone: (520) 290-9896
Fax: (520) 290-2508
Participants cannot be enrolled in the clinical study until they have signed an informed consent form, completed screening, and have been fully evaluated at the study site.
